Catecholamines: the first messengers

Allaf, 1984, Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure, Archives Internationales de Physiologie et de Biochimie, 92, S49, 10.3109/13813458409071161 Boudarius, 1983, Inotropic agents in the treatment of cardiogenic shock, Pharmacology and Therapeutics, 22, 53, 10.1016/0163-7258(83)90052-9 Braunwald, 1984, Vasodilator therapy of heart failure: has the promissory note been paid?, New England Journal of Medicine, 310, 459, 10.1056/NEJM198402163100711 Butterworth, 1992, Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery, Journal of Cardiothoracic and Vascular Anesthesia, 6, 535, 10.1016/1053-0770(92)90095-O Chatterjee, 1985, Neurohumoral abnormalities in heart failure, Heart Failure, 1, 69 Chernow, 1982, Endogenous and exogenous catecholamines in critical care medicine, Critical Care Medicine, 10, 409, 10.1097/00003246-198206000-00019 Chernow, 1984, Catecholamines in critical care medicine, vol. 2, 69 DeMay, 1981, Uneven distribution of postjunctional alpha1 and alpha2-like adrenoceptors in canine arterial and venous smooth muscle, Circulation Research, 48, 875, 10.1161/01.RES.48.6.875 Desjars, 1987, A reappraisal of norepinephrine therapy in human septic shock, Critical Care Medicine, 15, 134, 10.1097/00003246-198702000-00011 Desjars, 1989, Norepinephrine therapy has no deleterious renal effects in human septic shock, Critical Care Medicine, 17, 426, 10.1097/00003246-198905000-00010 DiSesa, 1991, Pharmacologic support for postoperative low cardiac output, Seminars in Thoracic and Cardiovascular Surgery, 3, 113 Fitton, 1990, Dopexamine hydrochloride, Drugs, 39, 308, 10.2165/00003495-199039020-00009 Ganguly, 1989, Catecholamines and cardiovascular disorders: pathophysiologic considerations, American Heart Journal, 118, 868, 10.1016/0002-8703(89)90610-8 Ghosh, 1991, Dopexamine hydrochloride: pharmacology and use in low cardiac output states, Journal of Cardiothoracic and Vascular Anesthesia, 5, 382, 10.1016/1053-0770(91)90166-Q Goldberg, 1989, The role of dopamine receptors in the treatment of congestive heart failure, Journal of Cardiovascular Pharmacology, 14, 521 Goldberg, 1989, Pharmacologic bases for the use of dopamine and related drugs in the treatment of congestive heart failure, Journal of Cardiovascular Pharmacology, 14, S21, 10.1097/00005344-198900148-00003 Goldstein, 1984, Effects of catecholamines in clinical heart disease, 327 Gollub, 1991, Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized double blind, parallel, placebo-controlled multi-center study, Journal of the American College of Cardiology, 18, 383, 10.1016/0735-1097(91)90590-6 Gray, 1991, A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation, Anaesthesia, 46, 638, 10.1111/j.1365-2044.1991.tb09711.x Guazzi, 1986, Hypersensitivity of lung vessels to catecholamines in systemic hypertension, British Medical Journal, 293, 291, 10.1136/bmj.293.6542.291 Hoefke, 1980 Hunter, 1989, The effects of dopexamine hydrochloride on cardiopulmonary haemodynamics following cardiopulmonary bypass surgery, International Journal of Cardiology, 23, 365, 10.1016/0167-5273(89)90197-6 Insell, 1989, Structure and function of α-adrenergic receptors, American Journal of Medicine, 87, 12S, 10.1016/0002-9343(89)90108-3 Jamison, 1989, Central and renal hemodynamic effects of a new agonist at peripheral dopamine and β2-adrenoreceptors (dopexamine) in patients with heart failure, American Heart Journal, 117, 607, 10.1016/0002-8703(89)90735-7 Jaski, 1988, Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine, American Journal of Cardiology, 62, 63C, 10.1016/S0002-9149(88)80070-5 Lawson, 1990, Therapeutic combinations of vasopressors and inotropic agents, Seminars in Anesthesiology, IX, 270 Lawson, 1992, Autonomic nervous system physiology and pharmacology, 319 Leir, 1991, Acute positive inotropic intervention: the catecholamines, American Heart Journal, 121, 1866, 10.1016/0002-8703(91)90077-U Leir, 1988, Cardiovascular pharmacology of dopexamine in low output congestive heart failure, American Journal of Cardiology, 62, 94, 10.1016/0002-9149(88)91371-9 Lokhandwala, 1990, Renal actions of dopexamine hydrochloride, Clinical Intensive Care, 1, 163 Lokhandwala, 1991, Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure, American Journal of Medicine, 90, 2S, 10.1016/0002-9343(91)90265-Y McGhie, 1992, Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy, Chest, 102, 626S, 10.1378/chest.102.5_Supplement_2.626S Maekawa, 1983, Comparison of dobutamine and dopamine in acute myocardial infarction, Circulation, 67, 750, 10.1161/01.CIR.67.4.750 Meadows, 1988, Reversal of intractable septic shock with norepinephrine therapy, Critical Care Medicine, 16, 663, 10.1097/00003246-198807000-00003 Meinertz, 1989, Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?, Basic Research in Cardiology, 84, 177, 10.1007/BF02650357 Motulsky, 1984, Radioligand binding to adrenergic receptors in humans, 271 Murphy, 1990, The therapeutic role of drugs acting on cardiovascular dopamine receptors, Journal of Cardiothoracic Anesthesia, 4, 23, 10.1016/0888-6296(90)90005-Z Murphy, 1990, Dopamine and dopamine receptor agonists in cardiovascular therapy, Critical Care Medicine, 18, S14 Noth, 1979, Tonic dopaminergic suppression of plasma aldosterone, Journal of Clinical Endocrinology and Metabolism, 51, 64, 10.1210/jcem-51-1-64 Perret, 1990, Acute heart failure in myocardial infarction: principles of treatment, Critical Care Medicine, 18, S26 Pierard, 1990, Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy, Journal of the American College of Cardiology, 15, 1021, 10.1016/0735-1097(90)90236-I Poelaert, 1989, Hemodynamic effects of dopexamine in patients following coronary artery bypass surgery, Journal of Cardiothoracic Anesthesia, 3, 441, 10.1016/S0888-6296(89)97555-8 Prichard, 1991, Heart and catecholamines, Acta Cardiologica, XLVI, 309 Pryce-Roberts, 1991, New developments in adrenergic pharmacology, Current Opinion in Anaesthesiology, 4, 111, 10.1097/00001503-199102000-00020 Pryce-Roberts, 1992, The changing face of adrenergic pharmacology, Current Opinion in Anaesthesiology, 5, 113, 10.1097/00001503-199202000-00019 Rafjer, 1987, Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: role of plasma catecholamines, Journal of the American College of Cardiology, 10, 1286, 10.1016/S0735-1097(87)80133-X Ramanathan, 1988, Vasopressor therapy for hypotension due to epidural anesthesia for cesarean section, Acta Anaesthesiologica Scandinavica, 32, 559, 10.1111/j.1399-6576.1988.tb02786.x Reinhart, 1990, Optimal oxygen delivery in critically ill patients, Intensive Care Medicine, 16, S149, 10.1007/BF01785245 Richard, 1983, Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock, Circulation, 67, S14, 10.1161/01.CIR.67.3.620 Royster, 1990, Intraoperative administration of inotropes in cardiac surgery patients, Journal of Cardiothoracic Anesthesia, 4, 17, 10.1016/0888-6296(90)90228-8 Schwinn, 1989, Time course and hemodynamic effects of alpha-1 adrenergic bolus administration in anesthetized patients with myocardial disease, Anesthesia and Analgesia, 68, 571, 10.1213/00000539-198905000-00005 Shoemaker, 1990, Therapy of shock based on pathophysiology, monitoring, and outcome prediction, Critical Care Medicine, 18, S19 Smith, 1987, Inhibition of uptake 1 in the dog by dopexamine hydrochloride, British Journal of Pharmacology, 92, 265, 10.1111/j.1476-5381.1987.tb11320.x Smith, 1970, The use and misuse of pressor agents, Anesthesiology, 8, 58, 10.1097/00000542-197007000-00019 Steen, 1978, Efficacy of dopamine, dobutamine and epinephrine during emergence from cardiopulmonary by pass in man, Circulation, 57, 378, 10.1161/01.CIR.57.2.378 Stephan, 1990, Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine, British Journal of Anaesthesia, 65, 380, 10.1093/bja/65.3.380 Stoelting, 1987, Sympathomimetics, 251 Stuart-Taylor, 1989, A plea for noradrenaline, Anaesthesia, 44, 916, 10.1111/j.1365-2044.1989.tb09148.x Tarnow, 1988, Altered hemodynamic response to dobutamine in relation to the degree of preoperative β-adrenoceptor blockade, Anesthesiology, 68, 912, 10.1097/00000542-198806000-00013 Tarnow, 1991, Cardiovascular effects of low-dose epinephrine infusions in relation to the extent of preoperative β-adrenoceptor blockade, Anesthesiology, 74, 1035, 10.1097/00000542-199106000-00011 Teich, 1985, Specific cardiovascular drugs utilized in the critically ill, Critical Care Clinics, 1, 491, 10.1016/S0749-0704(18)30641-9 Van Zwieten, 1988, The role of adrenoreceptors in circulatory and metabolic regulation, American Heart Journal, 116, 1384, 10.1016/0002-8703(88)90128-7 Vanhoutte, 1985, The heterogenicity of adrenergic receptors, 43 Vincent, 1990, Do we need a dopaminergic agent in the management of the critically ill?, Autonomic Pharmacology, 10, S123, 10.1111/j.1474-8673.1990.tb00238.x Zaritsky, 1983, Catecholamines, sympathomimetics, 481